BeOne Medicines (ONC) Selling, general & administrative expenses

annual SGA:

$1.83B+$323.06M(+21.42%)
December 31, 2024

Summary

  • As of today (June 22, 2025), ONC annual SGA is $1.83 billion, with the most recent change of +$323.06 million (+21.42%) on December 31, 2024.
  • During the last 3 years, ONC annual SGA has risen by +$840.93 million (+84.93%).
  • ONC annual SGA is now at all-time high.

Performance

ONC SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherONCincome statement metrics

quarterly SGA:

$459.27M-$45.41M(-9.00%)
March 1, 2025

Summary

  • As of today (June 22, 2025), ONC quarterly SGA is $459.27 million, with the most recent change of -$45.41 million (-9.00%) on March 1, 2025.
  • Over the past year, ONC quarterly SGA has increased by +$31.84 million (+7.45%).
  • ONC quarterly SGA is now -9.00% below its all-time high of $504.68 million, reached on December 31, 2024.

Performance

ONC quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherONCincome statement metrics

TTM SGA:

-$34.00B-$392.37M(-1.17%)
March 1, 2025

Summary

  • As of today (June 22, 2025), ONC TTM SGA is -$34.00 billion, with the most recent change of -$392.37 million (-1.17%) on March 1, 2025.
  • Over the past year, ONC TTM SGA has dropped by -$35.61 billion (-2216.39%).
  • ONC TTM SGA is now -55554.43% below its all-time high of -$61.09 million.

Performance

ONC TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherONCincome statement metrics

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

ONC Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+21.4%+7.5%-2216.4%
3 y3 years+84.9%+55.9%-3183.7%
5 y5 years+371.6%+328.9%-7191.1%

ONC Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+84.9%-9.0%+42.2%-63.2%at low
5 y5-yearat high+371.6%-9.0%+270.2%-300.1%at low
alltimeall timeat high>+9999.0%-9.0%>+9999.0%<-9999.0%at low

ONC Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Mar 2025
-
$459.27M(-9.0%)
$1.86B(+1.7%)
Dec 2024
$1.83B(+21.4%)
$504.68M(+10.9%)
$1.83B(+4.9%)
Sep 2024
-
$455.22M(+2.6%)
$1.74B(+5.4%)
Jun 2024
-
$443.73M(+3.8%)
$1.66B(+3.0%)
Mar 2024
-
$427.43M(+2.2%)
$1.61B(+6.6%)
Dec 2023
$1.51B(+17.9%)
$418.38M(+14.4%)
$1.51B(+6.2%)
Sep 2023
-
$365.71M(-7.4%)
$1.42B(+3.1%)
Jun 2023
-
$395.03M(+20.3%)
$1.38B(+4.8%)
Mar 2023
-
$328.50M(-0.4%)
$1.31B(+2.7%)
Dec 2022
$1.28B(+29.1%)
-
-
Dec 2022
-
$329.74M(+2.1%)
$1.28B(+1.9%)
Sep 2022
-
$322.89M(-2.6%)
$1.26B(+4.5%)
Jun 2022
-
$331.40M(+12.5%)
$1.20B(+9.0%)
Mar 2022
-
$294.57M(-3.9%)
$1.10B(+11.4%)
Dec 2021
$990.12M(+65.0%)
$306.50M(+13.8%)
$990.12M(+11.0%)
Sep 2021
-
$269.23M(+15.9%)
$891.83M(+13.8%)
Jun 2021
-
$232.29M(+27.6%)
$783.44M(+16.0%)
Mar 2021
-
$182.11M(-12.5%)
$675.20M(+12.5%)
Dec 2020
$600.18M(+54.6%)
$208.21M(+29.5%)
$600.18M(+12.1%)
Sep 2020
-
$160.84M(+29.7%)
$535.32M(+11.6%)
Jun 2020
-
$124.05M(+15.8%)
$479.49M(+9.6%)
Mar 2020
-
$107.08M(-25.3%)
$437.69M(+12.7%)
DateAnnualQuarterlyTTM
Dec 2019
$388.25M(+98.7%)
$143.35M(+36.5%)
$388.25M(+22.3%)
Sep 2019
-
$105.00M(+27.7%)
$317.38M(+21.5%)
Jun 2019
-
$82.25M(+42.7%)
$261.20M(+16.5%)
Mar 2019
-
$57.65M(-20.5%)
$224.12M(+14.7%)
Dec 2018
$195.38M(+212.1%)
$72.49M(+48.5%)
$195.38M(+30.0%)
Sep 2018
-
$48.82M(+8.1%)
$150.31M(+28.3%)
Jun 2018
-
$45.16M(+56.2%)
$117.13M(+41.6%)
Mar 2018
-
$28.91M(+5.5%)
$82.75M(+32.2%)
Dec 2017
$62.60M(+211.5%)
$27.41M(+75.3%)
$62.60M(+43.8%)
Sep 2017
-
$15.64M(+45.1%)
$43.52M(+33.5%)
Jun 2017
-
$10.78M(+22.9%)
$32.60M(+26.7%)
Mar 2017
-
$8.77M(+5.2%)
$25.73M(+28.0%)
Dec 2016
$20.10M(+174.9%)
$8.34M(+76.6%)
$20.10M(+36.6%)
Sep 2016
-
$4.72M(+21.0%)
$14.71M(+22.5%)
Jun 2016
-
$3.90M(+24.6%)
$12.01M(+28.9%)
Mar 2016
-
$3.13M(+6.2%)
$9.31M(+27.4%)
Dec 2015
$7.31M(+5.5%)
$2.95M(+46.0%)
$7.31M(+22.1%)
Sep 2015
-
$2.02M(+67.3%)
$5.99M(-22.9%)
Jun 2015
-
$1.21M(+6.7%)
$7.77M(+18.4%)
Mar 2015
-
$1.13M(-30.4%)
$6.56M(+20.9%)
Dec 2014
$6.93M(+120.5%)
$1.63M(-57.2%)
$5.43M(+42.8%)
Sep 2014
-
$3.80M
$3.80M
Dec 2013
$3.14M
-
-

FAQ

  • What is BeOne Medicines annual SGA?
  • What is the all time high annual SGA for BeOne Medicines?
  • What is BeOne Medicines annual SGA year-on-year change?
  • What is BeOne Medicines quarterly SGA?
  • What is the all time high quarterly SGA for BeOne Medicines?
  • What is BeOne Medicines quarterly SGA year-on-year change?
  • What is BeOne Medicines TTM SGA?
  • What is the all time high TTM SGA for BeOne Medicines?
  • What is BeOne Medicines TTM SGA year-on-year change?

What is BeOne Medicines annual SGA?

The current annual SGA of ONC is $1.83B

What is the all time high annual SGA for BeOne Medicines?

BeOne Medicines all-time high annual SGA is $1.83B

What is BeOne Medicines annual SGA year-on-year change?

Over the past year, ONC annual SGA has changed by +$323.06M (+21.42%)

What is BeOne Medicines quarterly SGA?

The current quarterly SGA of ONC is $459.27M

What is the all time high quarterly SGA for BeOne Medicines?

BeOne Medicines all-time high quarterly SGA is $504.68M

What is BeOne Medicines quarterly SGA year-on-year change?

Over the past year, ONC quarterly SGA has changed by +$31.84M (+7.45%)

What is BeOne Medicines TTM SGA?

The current TTM SGA of ONC is -$34.00B

What is the all time high TTM SGA for BeOne Medicines?

BeOne Medicines all-time high TTM SGA is -$61.09M

What is BeOne Medicines TTM SGA year-on-year change?

Over the past year, ONC TTM SGA has changed by -$35.61B (-2216.39%)
On this page